Santhera Pharmaceuticals Holding AG (SANN) — Long-term Investment Intensity
Santhera Pharmaceuticals Holding AG (SANN) has a Long-term Investment Intensity of 0.7% as of June 2019. Long-term investments of CHF712.00K represent 0.7% of total assets of CHF106.09 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check financial resilience of Santhera Pharmaceuticals Holding AG to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Santhera Pharmaceuticals Holding AG Long-term Investment Intensity (2014–2018)
This chart shows how Santhera Pharmaceuticals Holding AG's Long-term Investment Intensity has evolved across 5 annual periods from 2014 to 2018. As of June 2019, the intensity stands at 0.7%, reflecting long-term investments of CHF712.00K against total assets of CHF106.09 Million CHF. For the complete balance sheet picture, see SANN total asset value.
Annual Long-term Investment Intensity for Santhera Pharmaceuticals Holding AG (2014–2018)
The table below presents the year-by-year Long-term Investment Intensity for Santhera Pharmaceuticals Holding AG from 2014 to 2018, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Santhera Pharmaceuticals Holding AG debt and liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (CHF) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 0.6% | CHF690.00K | CHF110.29 Million | ▼ 0.0 pp |
| 2017 | 0.6% | CHF713.00K | CHF109.78 Million | ▲ +0.4 pp |
| 2016 | 0.3% | CHF270.00K | CHF90.79 Million | ▲ +0.1 pp |
| 2015 | 0.2% | CHF190.00K | CHF117.15 Million | ▼ -0.2 pp |
| 2014 | 0.4% | CHF85.00K | CHF22.95 Million | — |